Retout S, Gieschke R, Serafin D, Weber C, Frey N, Hofmann C. Disease Modeling and Model-Based Meta-Analyses to Define a New Direction for a Phase III Program of Gantenerumab in Alzheimer's Disease. Clin Pharmacol Ther. 2022 Apr;111(4):857-866. Epub 2022 Feb 28 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.